Screening asymptomatic organisms (humans, animals, plants) with a high‐diagnostic
accuracy using point‐of‐care‐testing (POCT) technologies, though still visionary holds great …

Introduction Pancreatic cancer is a highly aggressive cancer, and early diagnosis
significantly improves patient prognosis due to the early implementation of curative-intent …

Liquid biopsy, which is a minimally invasive procedure as an alternative to tissue biopsy,
has been introduced as a new diagnostic/prognostic measure. By screening disease-related …

Purpose The purpose of this study was to develop a radiomics-signature using computed
tomography (CT) data for the preoperative prediction of grade of nonfunctional pancreatic …

Objective Pancreatic ductal adenocarcinoma (PDAC) is commonly diagnosed at an
advanced stage. Liquid biopsy approaches may facilitate detection of early stage PDAC …

Proteins localized on the surface or within the lumen of tumor‐derived extracellular vesicles
(EVs) play distinct roles in cancer progression. However, quantifying both populations of …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a 5‐year
survival rate of 7.2% in China. However, effective approaches for diagnosis of PDAC are …

Background In the past decades, cancer enigmatical heterogeneity at distinct expression
levels could interpret disparities in therapeutic response and prognosis. It built hindrances to …

Objectives Cancer morbidity and mortality can be reduced if the cancer is detected early.
Cell-free DNA (cfDNA) fragmentomics emerged as a novel epigenetic biomarker for early …

Liquid biopsy is a noninvasive diagnostic technique used for monitoring cancer utilizing
specific genetic biomarkers present in bodily fluids, such as blood, saliva, or urine. These …